510(k) K233438— SleepStageML

Substantially Equivalent

Beacon Biosignals, Inc.

Clearance details

Applicant: Beacon Biosignals, Inc.
Product code: Code OLZ
Advisory panel: Neurology
Date received: 2023-10-13
Decision date: 2024-03-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Boston, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.